Carbometrics, in collaboration with Novo Nordisk and University of Bristol has published a paper in Nature magazine on t ...
RISK WARNING:
Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong.
NOT FOR RETAIL CLIENTS – The information contained on this website is solely intended for professional investors, defined as investors who (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive II (MiFID II) or (2) have requested to be treated as professional clients within the meaning of MiFID II.
Age related medical conditions account for over 60% of all loss of human life
Selvedge Venture invests into founders and start ups with a mission to allieviate the titanic healthcare burden caused by age-related medical conditions. We invest into Pre-Seed, Seed and Series A ready companies
We focus on three age related medical conditions
Metabolic Syndrome (Cardiovascular Disease, Diabetes, Fatty Liver Disease and Obesity), Cancer and Neurodegenerative Diseases. Each of these conditions accounts for a huge burden of both excess deaths and healthcare spend
Leveraging Biotechnology, Machine Learning Tools and Integrated Data Assets
Selvedge Venture’s core expertise is at the intersection of Biotechnology and Digital Technologies. Recent advances in the state of the art of both of these technologies provide a platform to shape healthcare and life sciences for many years to come
Three Selvedge Venture portfolio companies were featured in the April issue of Nature
Nature has published their April 2022 Biopharma Dealmakers collection on the Advances in Artificial Intelligence-Driven ...
On a journey to drastically speed up cell therapy manufacturing, Kytopen lands $30M Series A
Spun out of an MIT lab, sitting in an office space above a Cambridge tapas restaurant from world-renowned chef Ken Oring ...
SELECTED PORTFOLIO COMPANIES
Risk Warning
Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong.
NOT FOR RETAIL CLIENTS – The information contained on this website is solely intended for professional investors, defined as investors who (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive II (MiFID II) or (2) have requested to be treated as professional clients within the meaning of MiFID II.